Exploring the Ovarian Reserve Within Health Parameters: A Latent Class Analysis

Abstract

The process of ovarian aging is influenced by a complex and poorly understood interplay of endocrine, metabolic, and environmental factors. The purpose of this study was to explore the feasibility of using latent class analysis to identify subgroups based on cardiometabolic, psychological, and reproductive parameters of health and to describe patterns of anti-Müllerian hormone levels, a biomarker of the ovarian reserve, within these subgroups. Sixty-nine lean (body mass index [BMI] ⩽ 25 kg/m²) and severely obese (BMI ⩾ 40 kg/m²) postpartum women in Edinburgh, Scotland, were included in this exploratory study. The best fitting model included three classes: Class 1, n = 23 (33.5%); Class 2, n = 30 (42.2%); Class 3, n = 16 (24.3%). Postpartum women with lower ovarian reserve had less favorable cardiometabolic and psychological profiles. Examining the ovarian reserve within distinct subgroups based on parameters of health that affect ovarian aging may facilitate risk stratification in the context of ovarian aging.

Keywords

ovarian reserve latent class analysis cardiometabolic psychological

Get full access to this article

View all access options for this article.

References

Ahn

Corwin

E. J.

(2014). The association between breastfeeding, the stress response, inflammation, and postpartum depression during the postpartum period: Prospective cohort study. International Journal of Nursing Studies, 52, 1582-1590.

Balkan

Cetin

Usluogullari

C. A.

Unal

O. K.

Usluogullari

(2014). Evaluation of the ovarian reserve function in patients with metabolic syndrome in relation to healthy controls and different age groups. Journal of Ovarian Research, 7(1), Article 63.

Bleil

M. E.

Adler

N. E.

Pasch

L. A.

Sternfeld

Gregorich

S. E.

Rosen

M. P.

Cedars

M. I.

(2012a). Depressive symptomatology, psychological stress, and ovarian reserve: A role for psychological factors in ovarian aging? Menopause, 19, 1176-1185.

Bleil

M. E.

Adler

N. E.

Pasch

L. A.

Sternfeld

Gregorich

S. E.

Rosen

M. P.

Cedars

M. I.

(2012b). Psychological stress and reproductive aging among pre-menopausal women. Human Reproduction, 27, 2720-2728.

Bleil

M. E.

Bromberger

J. T.

Latham

M. D.

Adler

N. E.

Pasch

L. A.

Gregorich

S. E.

. . . Cedars

M. I.

(2013). Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause. Menopause, 20,631-639.

Bleil

M. E.

Gregorich

S. E.

McConnell

Rosen

M. P.

Cedars

M. I.

(2013). Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause, 20, 1139-1146.

Burnham

K. P.

Anderson

D. R.

(2003). Model selection and multimodel inference: A practical information-theoretic approach. Berlin, Germany: Springer.

Daan

N. M. P.

Fauser

B. C. J. M

. (2015). Menopause prediction and potential implications. Maturitas, 82, 257-265.

de Kat

A. C.

Broekmans

F. J. M.

Laven

J. S.

van der Schouw

Y. T

. (2015). Anti-Müllerian Hormone as a marker of ovarian reserve in relation to cardio-metabolic health: A narrative review. Maturitas, 80, 251-257.

10.

Dewailly

Alebić

Duhamel

Stojanović

(2014). Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles. Human Reproduction, 29, 2536-2543.

11.

Dewailly

Andersen

C. Y.

Balen

Broekmans

Dilaver

Fanchin

. . . Anderson

R. A.

(2014). The physiology and clinical utility of anti-Mullerian hormone in women. Human Reproduction Update, 20, 370-385.

12.

DiStefano

(2012). Cluster analysis and latent class clustering techniques. In Laursen

Little

T. D.

Card

N. A.

(Eds.), Handbook of developmental research methods (pp. 645-666). New York, NY: Guilford Press.

13.

Dolleman

Verschuren

W. M. M.

Eijkemans

M. J. C.

Dolle

M. E. T.

Jansen

E. H. J. M.

Broekmans

F. J. M.

van der Schouw

Y. T.

(2013). Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. The Journal of Clinical Endocrinology and Metabolism, 98, 2106-2115.

14.

Freeman

E. W.

Sammel

M. D.

Lin

Boorman

D. W.

Gracia

C. R.

(2012). Contribution of the rate of change of antimullerian hormone in estimating time to menopause for late reproductive-age women. Fertility and Sterility, 98(5), 1254e1-1259e2.

15.

Gerli

Favilli

Brozzetti

Torlone

Pugliese

Pericoli

. . . Falorni

(2015). Anti-Mullerian hormone concentration during the third trimester of pregnancy and puerperium: A longitudinal case-control study in normal and diabetic pregnancy. Endocrine, 50, 250-255.

16.

Goldberg

(1973). The detection of psychiatric illness by questionnaire. Psychological Medicine, 3, 257-264.

17.

Gunning

M. D.

Denison

F. C.

Stockley

C. J.

S. P.

Sandhu

H. K.

Reynolds

R. M.

(2010). Assessing maternal anxiety in pregnancy with the State-Trait Anxiety Inventory (STAI): Issues of validity, location and participation. Journal of Reproductive and Infant Psychology, 28, 266-273.

18.

Hardy

T. M.

McCarthy

D. O.

Fourie

N. H.

Henderson

W. A.

(2016). Anti-Müllerian hormone levels and urinary cortisol in women with chronic abdominal pain. Journal of Obstetric, Gynecologic, & Neonatal Nursing, 45, 772-780.

19.

Henry

Dymnicki

A. B.

Mohatt

Allen

Kelly

J. G.

(2015). Clustering methods with qualitative data: A mixed-methods approach for prevention research with small samples. Prevention Science: The Official Journal of the Society for Prevention Research, 16, 1007-1016.

20.

Iliodromiti

Kelsey

T. W.

Anderson

R. A.

Nelson

S. M.

(2013). Can anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. The Journal of Clinical Endocrinology and Metabolism, 98, 3332-3340.

21.

Jeppesen

J. V.

Anderson

R. A.

Kelsey

T. W.

Christiansen

S. L.

Kristensen

S. G.

Jayaprakasan

. . . Yding Andersen

(2013). Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Molecular Human Reproduction, 19, 519-527.

22.

Kaplan

(2014). Bayesian statistics for the social sciences. New York, NY: Guilford Press.

23.

Klenov

V. E.

Jungheim

E. S.

(2014). Obesity and reproductive function: A review of the evidence. Current Opinion in Obstetrics and Gynecology, 26, 455-460.

24.

Kok

H. S.

van Asselt

K. M.

van der Schouw

Y. T.

van der Tweel

Peeters

P. H. M.

Wilson

P. W. F.

. . . Grobbee

D. E.

(2006). Heart disease risk determines menopausal age rather than the reverse. Journal of the American College of Cardiology, 47, 1976-1983.

25.

Köninger

Kauth

Schmidt

Yerlikaya

Kasimir-Bauer

. . . Birdir

(2013). Anti-Mullerian-hormone levels during pregnancy and postpartum. Reproductive Biology and Endocrinology, 11(1), Article 60.

26.

Köninger

Schmidt

Mach

Damaske

Nießen

Kimmig

. . . Gellhaus

(2015). Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay. Reproductive Biology and Endocrinology, 13, Article 86.

27.

La Marca

Spada

Grisendi

Argento

Papaleo

Milani

Volpe

. (2012). Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. European Journal of Obstetrics & Gynecology and Reproductive Biology, 163, 180-184.

28.

Lamers

Vogelzangs

Merikangas

de Jonge

Beekman

Penninx

(2012). Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Molecular Psychiatry, 18, 692-699.

29.

Łebkowska

Adamska

Karczewska-Kupczewska

Nikołajuk

Otziomek

Milewski

. . . Kowalska

(2016). Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Metabolism, 65, 804-811.

30.

Leisch

(2004). FlexMix: A general framework for finite mixture models and latent class regression in R. Journal of Statistical Software, 11(8), 1-18.

31.

Leventhal

A. M.

Huh

Dunton

G. F.

(2014). Clustering of modifiable biobehavioral risk factors for chronic disease in US adults: A latent class analysis. Perspectives in Public Health, 134, 331-338.

32.

H. W. R.

Anderson

R. A.

Yeung

W. S. B.

P. C.

E. H. Y.

(2011). Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertility and Sterility, 96, 774-779.

33.

Malhotra

Bahadur

Singh

Kalaivani

Mittal

(2013). Does obesity compromise ovarian reserve markers? A clinician’s perspective. Archives of Gynecology and Obstetrics, 287, 161-166.

34.

Matthey

Ross-Hamid

(2012). Repeat testing on the Edinburgh Depression Scale and the HADS-A in pregnancy: Differentiating between transient and enduring distress. Journal of Affective Disorders, 141, 213-221.

35.

McClure

C. K.

Catov

J. M.

Ness

R. B.

Schwarz

E. B.

(2012). Lactation and maternal subclinical cardiovascular disease among premenopausal women. American Journal of Obstetrics and Gynecology, 207(1), 46.e1-46.e8.

36.

McNeilly

A. S.

(1993). Lactational amenorrhea. Neuroendocrinology II, 22, 59-73.

37.

Mina

T. H.

Denison

F. C.

Forbes

Stirrat

L. I.

Norman

J. E.

Reynolds

R. M.

(2015). Associations of mood symptoms with ante- and postnatal weight change in obese pregnancy are not mediated by cortisol. Psychological Medicine, 45, 3133-3146.

38.

Moy

Jindal

Lieman

Buyuk

(2015). Obesity adversely affects serum Anti-Müllerian Hormone (AMH) levels in Caucasian women. Journal of Assisted Reproduction and Genetics, 32, 1305-1311.

39.

Nelson

S. M.

Stewart

Fleming

Freeman

D. J.

(2010). Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertility and Sterility, 93, 1356-1358.

40.

Nikkheslat

Zunszain

P. A.

Horowitz

M. A.

Barbosa

I. G.

Parker

J. A.

Myint

A. M.

. . . Pariante

C. M.

(2015). Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain, Behavior, and Immunity, 48, 8-18.

41.

Ottinger

M. A.

(2011). Mechanisms of reproductive aging: Conserved mechanisms and environmental factors. Annals of the New York Academy of Sciences, 1204, 73-81.

42.

Pal

Bevilacqua

Santoro

N. F.

(2010). Chronic psychosocial stressors are detrimental to ovarian reserve: A study of infertile women. Journal of Psychosomatic Obstetrics & Gynecology, 31, 130-139.

43.

R Core Team. (2017). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available from https://www.r-project.org/

44.

Sahmay

Usta

Erel

C. T.

Imamoglu

Kücük

Atakul

Seyisoglu

(2012). Is there any correlation between AMH and obesity in premenopausal women. Archives of Gynecology and Obstetrics, 286, 661-665.

45.

Schliep

K. C.

Mumford

S. L.

Vladutiu

C. J.

Ahrens

K. A.

Perkins

N. J.

Sjaarda

L. A.

. . . Schisterman

E. F.

(2015). Perceived stress, reproductive hormones, and ovulatory function. Epidemiology, 26, 177-184.

46.

Steiner

A. Z.

(2013). Biomarkers of ovarian reserve as predictors of reproductive potential. Seminars in Reproductive Medicine, 31, 437-442.

47.

Tehrani

F. R.

Erfani

Cheraghi

Tohidi

Azizi

(2014). Lipid profiles and ovarian reserve status: A longitudinal study. Human Reproduction, 29, 2522-2529.

48.

Tein

J.-Y.

Coxe

Cham

(2013). Statistical power to detect the correct number of classes in latent profile analysis. Structural Equation Modeling, 20, 640-657.

49.

van Bussel

J. C. H.

Spitz

Demyttenaere

. (2006). Women’s mental health before, during, and after pregnancy: A population-based controlled cohort study. Birth, 33, 297-302.

50.

van Disseldorp

Faddy

M. J.

Themmen

A. P. N.

de Jong

F. H

Peeters

P. H. M.

van der Schouw

Y. T.

Broekmans

F. J. M

. (2008). Relationship of serum antimüllerian hormone concentration to age at menopause. The Journal of Clinical Endocrinology and Metabolism, 93, 2129-2134.

51.

Veen

Giltay

E. J.

DeRijk

R. H.

van Vliet

I. M.

van Pelt

Zitman

F. G.

(2009). Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism: Clinical and Experimental, 58, 821-827.

52.

Visser

J. A.

Durlinger

A. L. L.

Peters

I. J. J.

van den Heuvel

E. R.

Rose

U. M.

Kramer

. . . Themmen

A. P. N.

(2007). Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice. Endocrinology, 148, 2301-2308.

53.

Vryonidou

Paschou

S. A.

Muscogiuri

Orio

Goulis

D. G.

(2015). Metabolic syndrome through the female life cycle. European Journal of Endocrinology, 173(5), R153-R163.

54.

Williams

K. E.

Marsh

W. K.

Rasgon

N. L.

(2007). Mood disorders and fertility in women: A critical review of the literature and implications for future research. Human Reproduction Update, 13, 607-616.

55.

Wunder

D. M.

Bersinger

N. A.

Yared

Kretschmer

Birkhäuser

M. H.

(2008). Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertility and Sterility, 89, 927-933.